Tus kws kho mob
QP 102-22 MHCP Pharmacy Benefit Exclusion for Imjudo® and Tecvayli™
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 14, 2022
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1591 - 1600 ntawm 3685
Tus kws kho mob
QP106-22 MHCP Pharmacy Benefit Exclusion Floxuridine
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 14, 2022
Tus kws kho mob
QP109-22 New Provider Toolkit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 14, 2022
Tus kws kho mob
QP105-22 Provider Press Year-End 2022
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ob Hlis Ntuj Tim 14, 2022
Tus kws kho mob
Vtama (tapinarof) - Commercial
Kev Tso Cai Ua Ntej
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Camzyos™ (mavacamten) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 01, 2024
Tus kws kho mob
Vijoice (alpelisib) - Medicaid
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
Vijoice (alpelisib) - Commercial
Prior Authorization, Quantity Limit
Hnub Tim pib siv tau ntawm lub khoos kas: Rau Hlis Ntuj Tim 01, 2025
Tus kws kho mob
QP99-22 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective January 15, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 23, 2022